Sarode G, Maniyar N, Sarode SC, Jafer M, Patil S, Awan KH (2020) Epidemiologic aspects of oral cancer. Dis Mon 66(12):100988. https://doi.org/10.1016/j.disamonth.2020.100988
Malkani N, Kazmi S, Rashid UM (2021) Epidemiological Assessment of oral Cancer Burden in Pakistan. Cancer Invest 39(10):842–853. https://doi.org/10.1080/07357907.2021.1982962
Roi A, Roi CI, Andreescu NI, Riviş M, Badea ID, Meszaros N et al (2020) Oral cancer histopathological subtypes in association with risk factors: a 5-year retrospective study. Rom J Morphol Embryol 61(4):1213–1220. https://doi.org/10.47162/RJME.61.4.22
Miranda-Filho A, Bray F (2020) Global patterns and trends in cancers of the lip, tongue and mouth. Oral Oncol 102:104551. https://doi.org/10.1016/j.oraloncology.2019.104551
Freitas RSLS, Maia AC, Rodrigues RR, Rolim LSA, Souza LB, Andrade Santos PP (2021) Prevalence of lip and tongue squamous cell carcinoma (SCC) at a pathological anatomy service in Northeast Brazil. Int J Odontostomat 15(2):409–414
Wunschel M, Neumeier M, Utpatel K, Reichert TE, Ettl T, Spanier G (2021) Staging more important than grading? Evaluation of malignancy grading, depth of invasion, and resection margins in oral squamous cell carcinoma. Clin Oral Investig 25(3):1169–1182. https://doi.org/10.1007/s00784-020-03421-2
Almangush A, Mäkitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A et al (2020) Staging and grading of oral squamous cell carcinoma: an update. Oral Oncol 107:104799. https://doi.org/10.1016/j.oraloncology.2020.104799
Hu Y, Lv F, Li N, Yuan X, Zhang L, Zhao S et al (2023) Long noncoding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3. FEBS Open Bio 13(1):195–208. https://doi.org/10.1002/2211-5463.13532
Article CAS PubMed Google Scholar
Zhang Q, Qi T, Long Y, Li X, Yao Y, Wu Q et al (2022) GATA3 predicts the Tumor Microenvironment phenotypes and molecular subtypes for bladder carcinoma. Front Surg 12:9:860663. https://doi.org/10.3389/fsurg.2022.860663
Hernández-Guerrero JC, Jacinto-Alemán LF, Jiménez-Farfán MD, Macario-Hernández A, Hernández-Flores F, Alcántara-Vázquez A (2013) Prevalence trends of oral squamous cell carcinoma. Mexico City’s General Hospital experience. Med Oral Patol Oral Cir Bucal 18(2):e306–311. https://doi.org/10.4317/medoral.18043
Article PubMed PubMed Central Google Scholar
Almangush A, Bello IO, Keski-Säntti H, Mäkinen LK, Kauppila JH, Pukkila M et al (2014) Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck 36(6):811–818. https://doi.org/10.1002/hed.23380
Fang J, Li X, Ma D, Liu X, Chen Y, Wang Y et al (2017) Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. BMC Cancer 17(1):375. https://doi.org/10.1186/s12885-017-3317-2
Article CAS PubMed PubMed Central Google Scholar
Ebrahimi A, Gil Z, Amit M, Yen TC, Liao CT, Chaturvedi P et al (2019) International Consortium for Outcome Research (ICOR) in Head and Neck Cancer. Depth of invasion alone as an indication for postoperative radiotherapy in small oral squamous cell carcinomas: an International Collaborative Study. Head Neck 41(6):1935–1942. https://doi.org/10.1002/hed.25633
Article PubMed PubMed Central Google Scholar
Wetzel M, Strickley J, Haeberle MT, Brown TS (2019) Depth of Invasion of Aggressive and nonaggressive basal cell carcinoma. J Clin Aesthet Dermatol 12(3):12–14
PubMed PubMed Central Google Scholar
Bai F, Zheng C, Liu X, Chan HL, Liu S, Ma J et al (2022) Loss of function of GATA3 induces basal-like mammary tumors. Theranostics 12(2):720–733. https://doi.org/10.7150/thno.65796
Article CAS PubMed PubMed Central Google Scholar
Mc Donald TM, Epstein JI (2021) Aberrant GATA3 staining in Prostatic Adenocarcinoma: a potential diagnostic pitfall. Am J Surg Pathol 45(3):341–346. https://doi.org/10.1097/PAS.0000000000001557
Zhang Z, Fang X, Xie G, Zhu J (2021) GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression. Oncol Lett 21(3):231. https://doi.org/10.3892/ol.2021.12492
Article CAS PubMed PubMed Central Google Scholar
Medeiros Souza P, Carvalho FM, Aguiar FN, Gagliato D, Dornellas de Barros ACS (2022) Association between GATA3 and histopathological and immunohistochemical parameters in Early-Infiltrating Breast Carcinomas. Eur J Breast Health 18(3):229–234
Article PubMed PubMed Central Google Scholar
Wang W, Wang M, Xu J, Long F, Zhan X (2020) Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b. Cancer Cell Int 20:339. https://doi.org/10.1186/s12935-020-01424-3
Article CAS PubMed PubMed Central Google Scholar
El-Arabey AA, Denizli M, Kanlikilicer P, Bayraktar R, Ivan C, Rashed M et al (2020) GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal 68:109539. https://doi.org/10.1016/j.cellsig.2020.109539
Article CAS PubMed Google Scholar
Chi Z, Balani J, Gopal P, Hammer S, Xu J, Peng L (2022) GATA3 positivity is associated with poor prognosis in patients with oesophageal squamous cell carcinoma. J Clin Pathol 17:208035. https://doi.org/10.1136/jclinpath-2021-208035
Guo W, Lee W, Lu Y, Li X, Chandan VS (2020) Incidence and significance of GATA3 positivity in gallbladder adenocarcinoma. Hum Pathol 106:39–44. https://doi.org/10.1016/j.humpath.2020.09.012
Article CAS PubMed Google Scholar
Sun J, Liu S, Fu K, Gao N, Li R, He W, Gao Z (2021) Clinicopathological characteristics and outcomes of 23 patients with secretory carcinoma of major salivary glands. Sci Rep 22(1):22639. https://doi.org/10.1038/s41598-021-01970-4
Comments (0)